Dr Athina Giovanis, DO | |
1351 S County Trl Ste 100, East Greenwich, RI 02818-5079 | |
(401) 886-5907 | |
(401) 885-6071 |
Full Name | Dr Athina Giovanis |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1351 S County Trl Ste 100, East Greenwich, Rhode Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629262035 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 252551 (New York) | Secondary |
204D00000X | Neuromusculoskeletal Medicine & Omm | 252551 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Athina Giovanis, DO 1351 S County Trl Ste 100, East Greenwich, RI 02818-5079 Ph: (401) 886-5907 | Dr Athina Giovanis, DO 1351 S County Trl Ste 100, East Greenwich, RI 02818-5079 Ph: (401) 886-5907 |
News Archive
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
New research published in the British Journal of Educational Psychology suggests that sleep problems may negatively affect children's reading ability.
Medsphere Systems Corporation, Phoenix Health Systems and Guadalupe County Hospital today announced Guadalupe's selection of Phoenix's Total IT Solution featuring Medsphere's OpenVista® electronic health record. Phoenix IT expertise paired with Medsphere's open-source EHR solution will enable this 10-bed Santa Rosa, N.M., acute-care hospital to secure federal stimulus support for health IT implementation while improving patient care.
AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies, today announced that detailed preclinical results with its monoclonal antibody mAB C6-17 to treat Huntington's Disease were published in the peer-reviewed journal Neurobiology of Disease.
Young women who were treated for cancer as children have a greater chance of developing breast cancer if their treatment included chest radiation, if they initially had cancer of the bones, muscles, or connective tissue, or had a family history of breast cancer
› Verified 1 days ago